Results from REACH1, a Single-Arm Phase 2 Study of Ruxolitinib in Combination with Corticosteroids for the Treatment of Steroid-Refractory Acute Graft-Vs-Host Disease
Conclusion:In this first prospective trial of RUX in pts with SR aGVHD, RUX treatment resulted in overall responses in 54.9% of pts with SR aGVHD by Day 28, many of whom (68%) had grade III/IV disease at baseline. Best ORR at any time was 73.2% (CR, 56.3%). Responses were rapid and durable. Most pts achieved sustained reductions in CS dose. The AE profile was consistent with expectations for RUX and pts with SR aGVHD. RUX represents a promising therapeutic strategy; a phase 3 trial of RUX vs best available therapy in SR aGVHD is underway.DisclosuresJagasia: Incyte Corporation: Membership on an entity's Board of Directors or advisory committees. Perales: Merck: Other: Personal fees; Abbvie: Other: Personal fees; Takeda: Other: Personal fees; Novartis: Other: Personal fees; Incyte: Membership on an entity's Board of Directors or advisory committees, Other: Personal fees and Clinical trial support. Schroeder: Incyte Corporation: Membership on an entity's Board of Directors or advisory committees. Ali: Incyte Corporation: Membership on an entity's Board of Directors or advisory committees. Shah: Lentigen Technology: Research Funding; Miltenyi: Other: Travel funding, Research Funding; Juno Pharmaceuticals: Honoraria; Geron: Equity Ownership; Exelexis: Equity Ownership; Oncosec: Equity Ownership. Chen: Magenta Therapeutics: Consultancy; Takeda Pharmaceuticals: Consultancy; Incyte: Consultancy, Membership on an entity's Board of Directors or advisory committees; REGiMMUNE: Consultan...
Source: Blood - Category: Hematology Authors: Jagasia, M., Perales, M.-A., Schroeder, M. A., Ali, H., Shah, N. N., Chen, Y.-B., Arbushites, M. C., Dawkins, F., Tian, C., Khoury, H. J. Tags: 722. Clinical Allogeneic Transplantation: Acute and Chronic GVHD, Immune Reconstitution: GVHD Treatment and Prevention Strategies Source Type: research
More News: Acute Leukemia | Acute Myeloid Leukemia | Anemia | Cancer & Oncology | Chronic Leukemia | Clinical Trials | Corticosteroid Therapy | Cytomegalovirus | Employment | Gastroenterology | Hematology | Leukemia | Merck | Myelodysplastic Syndrome | Skin | Skin Graft | Stem Cell Therapy | Stem Cells | Study | Transplants